Un brote por Mycobacterium chelonae, subespecie abscessus asociado a hiposensibilización en pacientes alérgicos

Estrada, Santiago; Díaz, Javier; Jaramillo, Edilma; Mejía, Gloria I; Orozco, Beatriz; Posada, Patricia; Restrepo, Marcos.
Acta méd. colomb ; 17(2): 72-6, mar.-abr. 1992. ilus, tab
Artículo en Español | LILACS | ID: lil-183221

Documentos relacionados

  1. [The route is the destination-novel forms of application of allergen immunotherapy].
  2. Subcutaneous immunotherapy with aeroallergens: safety profile assessment.
  3. Information needs of patients considering oral immunotherapy for food allergy.
  4. Carbohydrates in allergy: from disease to novel immunotherapies.
  5. A regulator's view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure.
  6. Sustained unresponsiveness development in wheat oral immunotherapy: predictive factors and flexible regimen in the maintenance phase.
  7. Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy.
  8. [GUIDE OF ALLERGEN IMMUNOTHERAPY].
  9. Reply.
  10. Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy.